Patents by Inventor Scott Power

Scott Power has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040029232
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
    Type: Application
    Filed: August 4, 2003
    Publication date: February 12, 2004
    Applicant: Tularik Inc.
    Inventors: Scott Powers, Jianxin Yang, Gene Cutler
  • Publication number: 20040005596
    Abstract: There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the CTSZ and CD24 genes, which are amplified colon cancer and/or ovarian cancer and/or breast cancer genes. The CTSZ and CD24 genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or vaccine; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
    Type: Application
    Filed: March 18, 2003
    Publication date: January 8, 2004
    Inventors: Jing Li, Scott Powers, Jianxin Yang
  • Patent number: 6638733
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: October 28, 2003
    Assignee: Tularik Inc.
    Inventors: Scott Powers, Jianxin Yang, Gene Cutler
  • Patent number: 6635741
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
    Type: Grant
    Filed: April 11, 2000
    Date of Patent: October 21, 2003
    Assignee: Tularik Inc.
    Inventors: Scott Powers, Jianxin Yang, Gene Cutler
  • Publication number: 20030175763
    Abstract: There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the ACK1 gene, which are amplified breast and/or ovarian and/or prostate cancer genes. The ACK1 gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or vaccine; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
    Type: Application
    Filed: December 13, 2002
    Publication date: September 18, 2003
    Inventors: Yan Y. Degenhardt, Scott Powers
  • Publication number: 20030092042
    Abstract: There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals such as humans, utilizing the Galanin, Galanin Receptor 2 (GALR2) and Galanin Receptor 3 (GALR3) genes, which are amplified in breast and/or lung and/or brain and/or colon and/or prostate and/or ovarian cancer genes. The Galanin, GALR2 and GALR3 genes and their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or vaccine; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy. There is also disclosed a GALR2-GALR3 heterocomplex formation during tumorigenesis.
    Type: Application
    Filed: August 27, 2002
    Publication date: May 15, 2003
    Inventors: David Mu, Scott Powers
  • Publication number: 20030049645
    Abstract: There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the hepsin gene, which are amplified ovarian, and/or prostate, and/or breast, and/or lung cancer genes. The hepsin gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
    Type: Application
    Filed: February 12, 2002
    Publication date: March 13, 2003
    Inventors: David Mu, Scott Powers
  • Publication number: 20030044814
    Abstract: The present invention provides nucleic acid and protein sequences for a novel protein, PRC17, and methods, reagents, and kits for diagnosing and treating cancer in a mammal, e.g., a human. This invention is based upon the discovery that the novel PRC17 is overexpressed and/or amplified in cancer. Methods to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and to treat cancer, by inhibiting the expression and/or activity of PRC17 in a cancer cell are included.
    Type: Application
    Filed: February 8, 2002
    Publication date: March 6, 2003
    Applicant: Tularik Inc.
    Inventors: Jing Li, Scott Powers, Phil Xiang, Yue Peng
  • Publication number: 20030032027
    Abstract: There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the WIP1 gene, which are amplified breast, and/or lung, and/or colon, and/or ovarian, and/or prostate cancer genes. The WIP1 gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
    Type: Application
    Filed: February 12, 2002
    Publication date: February 13, 2003
    Inventors: Jing Li, Scott Powers
  • Publication number: 20020150934
    Abstract: The present invention provides methods, reagents, and kits for diagnosing and treating cancer in a mammal, e.g., a human. This invention is based upon the discovery that Pellino 1 or 2 is overexpressed and/or amplified in cancer. Methods to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and to treat cancer, by inhibiting the expression and/or activity of Pellino 1 or 2 in a cancer cell are included.
    Type: Application
    Filed: December 28, 2001
    Publication date: October 17, 2002
    Applicant: Tularik Inc.
    Inventors: Scott Powers, David Mu, Phil Xiang, Yue Peng
  • Publication number: 20020102676
    Abstract: The present invention provides nucleic acid and protein sequences for a novel potassium channel protein, KCNB. The herein-disclosed sequences can be used for any of a number of purposes, including for the specific detection of KCNB, for the identification of molecules that associate with and/or modulate the activity of KCNB, to diagnose any of a number of conditions associated with KCNB or KCNB activity, or to modulate the number or activity of KCNB molecules in a mammal.
    Type: Application
    Filed: March 2, 2001
    Publication date: August 1, 2002
    Inventors: David Mu, Scott Powers
  • Patent number: 6372444
    Abstract: The invention provides methods and compositions for diagnosing and treating tumors. In particular embodiments, the invention provides methods for characterizing tumors for SODD gene copy number and/or expression and for using this diagnosis in guiding treatment options. Accordingly, the invention provides methods for biasing therapeutic options by (a) contacting a biopsy of a tumor with an agent which specifically binds a SODD gene or SODD gene product thereof; (b) measuring specific binding of the agent to the SODD gene or gene product to determine an amount of the SODD gene or gene product present in the biopsy; and (c) biasing therapeutic options for treating the tumor based on the amount of the SODD gene or gene product present in the biopsy.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: April 16, 2002
    Assignee: Tularik Inc.
    Inventors: Scott Powers, Rong Wendy Zeng
  • Patent number: 5984845
    Abstract: A body stretching apparatus includes two handgrip placement straps which are connected to a foot support device. Handgrips are installed onto the handgrip placement strap which are held in place by clips. Adjustable clips allow the handgrip placement straps to be adjusted to proper length. In operation, an operator sits on the floor in a "pike" position, grasping the hand grips in stages to stretch the legs and lower back. The individual handgrips are color-coded or otherwise marked with indicia to indicate different levels of stretching ability. The handgrips are conically shaped to make it easier for the operator to grip. In one embodiment, a back support and back strap helps to position the operator's upper body to prevent injury to the operator's lower back. In another embodiment, adjustable slides on the back strap shorten a distance between clasps on the ends of said back strap.
    Type: Grant
    Filed: January 6, 1999
    Date of Patent: November 16, 1999
    Assignee: Stretch Rite, Inc.
    Inventor: Scott Powers
  • Patent number: 5525490
    Abstract: The reverse two-hybrid method has been designed to provide a practical and efficient means of utilizing yeast cell-based assays to screen for molecules that can inhibit protein-protein interactions of interest. Existing two-hybrid systems involve reconstitution in yeast of a transcriptional activator that drives expression of a "reporter" gene such as HIS3 or lacZ. Attempts to utilize these existing systems for drug discovery would necessarily involve screening for molecules that interfere with the transcriptional read-out, and would be subject to detecting any compound that non-specifically interfered with transcription. In addition, since currently used reporter genes encode long-lived proteins, the assay would have to be performed over a lengthy time period to allow for decay of the preexisting reporter proteins. Any compound that would be toxic to yeast over this time period would also score as a "hit".
    Type: Grant
    Filed: March 29, 1994
    Date of Patent: June 11, 1996
    Assignee: ONYX Pharmaceuticals, Inc.
    Inventors: James R. Erickson, Scott Powers
  • Patent number: 5004228
    Abstract: A leg stretching apparatus comprises two handgrip placement straps which are connected to a foot support member. Handgrips are threaded onto the handgrip placement strap which are held in place by adjustable clips. The adjustable clips allow the handgrips to be adjusted to proper length. In operation, an individual sits on the floor in a "pike" position, grasping the handgrips in stages to stretch the legs and lower back.
    Type: Grant
    Filed: April 20, 1989
    Date of Patent: April 2, 1991
    Inventor: Scott Powers